N. Vegas-Revenga

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

N. Vegas-Revenga, V. Calvo-Río, Marina Mesquida et al. · American Journal of Ophthalmology · 2019 · 111 citations · Full text

Ocular Disease, Ophthalmology, Anti-il6-receptor Tocilizumab +5

Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study

Belén Atienza‐Mateo, V. Calvo-Río, E. Beltrán et al. · Lara D. Veeken · 2018 · 104 citations

Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study

Alfonso Corrales, N. Vegas-Revenga, Javier Rueda‐Gotor et al. · Seminars in Arthritis and Rheumatism · 2020 · 42 citations

Rheumatoid Disorder, Rheumatology, Vascular Disease +13

Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients

L Domínguez-Casas, L. Sánchez-Bilbao, V. Calvo-Río et al. · Seminars in Arthritis and Rheumatism · 2020 · 41 citations

Ophthalmology, Medicine, Clinical Dermatology +6

Long-term Follow-up and Optimization of Infliximab in Refractory Uveitis Due to Behçet Disease: National Study of 103 White Patients

J. L. Martín-Varillas, Belén Atienza‐Mateo, V. Calvo-Río et al. · The Journal of Rheumatology · 2020 · 28 citations